We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Low Sales Prompt Bankruptcy Filing for New Jersey Biotech
Low Sales Prompt Bankruptcy Filing for New Jersey Biotech
October 18, 2013
Savient Pharmaceuticals said last week it has filed for Chapter 11 bankruptcy and will look to auction off all of its assets to a suitor, including its flagship gout drug Krystexxa.